UK Edition
AdvertiseSubmit Company
Pharma JournalEvidence-Based Pharmaceutical Intelligence
RESEARCH & DEVELOPMENT

Akari Therapeutics

Akari Therapeutics logo

Akari Therapeutics

Visit WebsiteContact Company

About Akari Therapeutics

In the UK, Akari Therapeutics was founded in 2005. We create complement (C5) and leukotriene (LTB4) pathway-based therapies for autoinflammatory disorders that have the power to change people's lives.

Similar Companies

More in Research & Development

A

AOP Orphan

AOP Orphan is a leader in Europe when it comes to the development, manufacturing, and marketing of medications for patients with uncommon and unique disorders. AOP Orphan is a privately held firm committed to continuity, high quality, and commitment for the long term.

View profile
A

Actimed Therapeutics

With a goal of transforming care for a patient population that is underserved and vulnerable, extending and improving the quality of their lives, restoring their dignity, and lessening the burden on the patient, caregiver, and provider, we are concentrated on bringing innovation to the treatment of cachexia.

View profile
4

4DMT

Our "disease first" approach to product discovery and development at 4DMT allows us to tailor our AAV vectors to target particular tissue types linked to the underlying condition. This is made possible by our revolutionary discovery platform, Therapeutic Vector Evolution.

View profile
AdvertisementTeksyte LTD

List Your Company

Showcase your company to thousands of pharma professionals.

Submit Listing

Advertise With Us

Reach decision-makers in the pharmaceutical industry.

Learn More

We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy